Painless myocardial ischemia is associated with mortality in patients with chronic kidney disease

James B Wetmore1, Mike Broce, Amer Malas

  • 1Division of Nephrology and Hypertension, University of Kansas Medical Center, Kansas City, Kans 66160, USA. jwetmore @ kumc.edu

Insights

Painless myocardial ischemia (PMI) is common in chronic kidney disease (CKD) patients and linked to lower kidney function. This condition significantly increases mortality risk in CKD individuals.

Area of Science:

  • Cardiology
  • Nephrology
  • Clinical Outcomes Research

Background:

  • Painless myocardial ischemia (PMI) is linked to adverse outcomes in the general population.
  • Chronic kidney disease (CKD) is associated with increased cardiovascular risk and mortality.
  • The relationship between PMI, kidney function, and survival in CKD patients remains unclear.

Purpose of the Study:

  • To investigate the prevalence of PMI in patients with varying levels of kidney function.
  • To determine the association between PMI, CKD, and long-term mortality.
  • To explore if PMI contributes to the high cardiovascular mortality observed in CKD.

Main Methods:

  • A cohort of 356 patients undergoing percutaneous coronary intervention were evaluated.
  • Painless myocardial ischemia (PMI) was defined as the absence of chest pain during balloon angioplasty.
  • Cox proportional hazards models were used to assess 10-year all-cause mortality risk.

Main Results:

  • PMI prevalence increased with declining estimated glomerular filtration rate (eGFR), from 20.6% (eGFR ≥ 90) to 50.0% (eGFR < 30).
  • Individuals with both CKD and PMI exhibited the highest 10-year mortality risk (HR 2.08).
  • CKD alone was associated with increased mortality (HR 1.64) compared to those without CKD or PMI.

Conclusions:

  • Painless myocardial ischemia is highly prevalent in the CKD population and inversely correlates with eGFR.
  • PMI significantly elevates mortality risk in CKD patients, potentially explaining some of the excess cardiovascular mortality.
  • These findings highlight the importance of identifying PMI in CKD patients for risk stratification and management.
Abstract

Related Concept Videos

Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of fluid...
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
Acute Kidney Injury I: Introduction01:22

Acute Kidney Injury I: Introduction

Introduction:Acute Kidney Injury (AKI) describes a swift decrease in kidney function occurring over hours to days, characterized by the kidneys' failure to remove waste products from the bloodstream. This leads to dangerous complications like metabolic acidosis, fluid overload, and electrolyte imbalances, such as hyperkalemia, which can cause life-threatening arrhythmias. AKI is common in both hospital and outpatient settings, often triggered by dehydration, sepsis, or exposure to nephrotoxic...